Recently, there has been a surge in search frequency for Xenofocus, known as an enzyme specialist company.


As of 10:31 AM on the 28th, Xenofocus's stock price rose 29.88% from the previous day to 16,300 KRW, with a trading volume of 4,197,935 shares, which is 263.21% of the 5-day average trading volume.


On August 27, Xenofocus became a market issue with the announcement of a "30% increase in enzyme development for COVID-19 diagnosis."



※Source: AI Investment Assistant AI Rasero


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing